Overview

Dashboard News

ubs downgrades mercedes while upgrading bmw amid market challenges

UBS has downgraded Mercedes-Benz to "neutral" with a target price of €55, citing challenges in its core business and a tough outlook for 2025, including a projected 10-12% decline in earnings per share. In contrast, BMW has been upgraded to "buy" with a new target of €83, supported by strong cash returns and a favorable position regarding CO2 regulations, despite potential risks in the Chinese market.
Investing.com India
Euro United States Dollar Mercedes-Benz Group AG DEU CHN USA Show more
TradFi, Market Report
13:58 03.12.2024

customized market research solutions for strategic business success and growth

Customized market analysis services offer clients tailored insights to navigate market opportunities and challenges effectively. With options for 20% customization, the ability to select five countries and companies, and 40 hours of free customization, clients receive comprehensive support, including one year of after-sales assistance. The reports provide in-depth analysis of market segments, trends, and competitive landscapes, empowering stakeholders to make informed decisions.
openPR.com
United States Dollar Oracle Corporation SAP SE McKesson Corporation Cerner Corporation Zebra Technologies Corp Philips Healthcare AT&T Inc. Cisco Systems, Inc. OMRON Corporation Airstrip Technologies, Inc. Microsoft Corporation Apple Inc. QUALCOMM Incorporated IBM Corporation Hewlett-Packard (HP) Inc. Show more
Healthcare, Market Report
13:54 03.12.2024

ubs upgrades bmw to buy citing strong financial position and margins

UBS has upgraded BMW's stock from Neutral to Buy, raising the price target to €83.00, citing strong financial stability and anticipated cash returns to shareholders. The firm expects a stable automotive EBIT margin of 6.5% and predicts a yield of around 15% through dividends and buybacks, positioning BMW as a top pick in the European automotive sector.
investing.com
Euro Bayerische Motoren Werke AG DEU
TradFi, Market Report
13:54 03.12.2024

trane technologies to present at ub s global conference on december third

Trane Technologies plc (TT) is set to present at the UBS Global Industrials and Transportation Conference on December 3, 2024, starting at 8:50 AM ET. The live webcast can be accessed through their investor relations website.
@Nasdaq
Trane Technologies plc IRL
TradFi, Press Release
13:54 03.12.2024

gestamp shares decline as barclays and ubs downgrade ratings amid challenges

Gestamp Automoción S.A. shares fell over 5% after downgrades from Barclays and UBS, citing concerns over free cash flow and subdued production levels in Western Europe, which constitutes 35-40% of sales. UBS lowered its price target to €2, while Barclays adjusted its target to €3.0, highlighting ongoing challenges in North America and the impact of rising capital expenditures amid a declining vehicle production outlook in Europe.
Investing.com
Euro Barclays PLC Stellantis N.V. ESP MEX GBR CHN USA Show more
TradFi, Market Report
13:40 03.12.2024

global medical waste management market trends and key players analysis

The global medical waste management market encompasses various waste generators, including hospitals, diagnostic laboratories, and pharmaceutical manufacturers, producing hazardous and non-hazardous waste. Key service types include collection, treatment, and disposal methods such as incineration and recycling. Major players in the industry include Stericycle, Veolia Environment, and Clean Harbours, reflecting a diverse landscape of companies addressing the critical need for effective waste management solutions.
GlobeNewswire News Room
ACE Waste AZZ Green Waste Management Al Dharfa Waste Collection Alba Services Ltd. Allied USA All Medical Waste Australia ARTECH Reduction Technologies Averda Waste Management Axil Integrated Service BVG India Ltd. BWS, Inc. Bertin Medical Waste Biffa Waste Services Ltd. Biomedical Waste Solutions BioSter Biotic Waste Bondtech Bradford White Casella Waste Systems, Inc. Clean Harbours Cleanaway Waste Management Ltd ClinX Medical Waste Management Compass Medical Waste Services Condor Medical Waste Treatment Co Converge Medical Solutions Covanta Holding Corporation Curtis Bay Medical Waste Services Daniels Health Daniels Sharpsmart DILO Armaturen und Anlagen GmbH DULSCO E-Coli Waste Management Ecomed Services Eco Medical EKOMED Environmental Waste International Inc. EPCO Co.,Ltd. GIC Medical Disposal GRP & Associates, Inc. Gamma Waste Systems Globalex Enviro LLC GreenTech Environ Management Green Mountains Environment and Transport Services Groupe Atlantic Hanjer Biotech Energies Hawaii Bio-Waste Systems Hazardous Waste Experts Heritage Environmental Services Initial Medical Kudoti Lamor Corporation Oyj Linder-Recyclingtech Mazaya Waste Management Med-X Waste Solutions Medasend Biomedical Medicare Group Q.P.S.C. MediSort MedPro Disposal MedWaste Industries MedWaste Management Myron L Company PHS Group Passco Environmental Solutions Picvisa Machine Vision Systems SL Pilot Performance Resources Management Presona Pro-Disposal Medical Waste Services Propex Operating Co Remondis Republic Services, Inc. Restore Health Medicare SMS Envocare SSO Medical Waste Management Safeguard Waste Solutions San-I-Pak Pacific, Inc. Sanpro Medical Waste Disposal Sharps Compliance Stericycle Inc STI BioSAFE Suez Environment Tana Oy Tatva Global Environment Ltd The Mark-Costello Co The SafeGroup Trilogy MedWaste Triumvirate Environmental US Ecology, Inc. United Medical Waste Management Veolia Environment Waste Management, Inc. Wastex WM Intellectual Property Holdings Show more
Healthcare, Market Report
13:37 03.12.2024

Bristol Myers Squibb Sues HHS Over Controversial 340B Rebate Model Changes

Bristol Myers Squibb has filed a lawsuit against the federal government over a rejected plan to implement a 340B rebate model for drug discounts to hospitals, claiming the decision by HHS was unlawful. The company argues that its model would enhance compliance and transparency while addressing issues of abuse within the program. BMS intends to start this model with its Eliquis product in spring 2025, despite HHS's disapproval citing statutory inconsistencies.
Fierce Healthcare
Johnson & Johnson Eli Lilly and Co Bristol-Myers Squibb Co USA Show more
Regulatory & Legal, Press Release
13:30 03.12.2024

ubs maintains buy rating on stellantis with target price of 16 euros

UBS has maintained a "Buy" rating on Stellantis with a target price of 16 euros, despite uncertainties surrounding leadership changes. Analyst Patrick Hummel suggests that the automotive group's investment potential could gain traction, positioning it as a compelling option for a turnaround in 2025.
boerse.de
Euro Stellantis N.V. ITA Patrick Hummel
TradFi, Market Report
13:28 03.12.2024

healthcare cyber security market analysis and growth forecast for 2024 to 2031

Priya Pandey, a skilled PR writer with a background in biotechnology, excels in content creation across various industries, including healthcare and technology. Coherent Market Insights offers comprehensive market intelligence and consulting services, focusing on actionable insights and reliable reports in sectors like aerospace, automotive, and food and beverages. The latest report analyzes the Healthcare Cyber Security Market, highlighting key players, market trends, and growth opportunities from 2024 to 2031.
openPR.com
United States Dollar IBM Corporation Lockheed Martin Corporation Cisco Systems Inc Northrop Grumman Corporation Intel Security Group (McAfee) Canoo Inc. Booz Allen Hamilton Inc. Computer Sciences Corporation Inc. Symantec Corporation Trend Micro Incorporated USA CAN MEX DEU GBR FRA ITA RUS ESP CHN IND JPN SGP AUS NZL BRA ARG TUR SAU IRN ARE Priya Pandey Show more
Technology & Innovation, Market Report
13:20 03.12.2024

trafigura faces bribery trial as key witness testimony is upheld in switzerland

Trafigura's legal attempt to dismiss evidence from star witness Mariano Marcondes Ferraz in a Swiss bribery trial was rejected by judges in Bellinzona. The case marks a historic moment as it is the first time a commodity trading company faces corruption charges in Switzerland, with allegations of over €5mn paid to an Angolan official for oil shipment rights. The trial will proceed, with the credibility of Ferraz's testimony assessed on its merits, despite arguments regarding a potential illegal plea bargain and the death of Trafigura's former CEO, Claude Dauphin.
@FinancialTimes
Euro Trafigura Beheer BV AGO Michael Wainwright Claude Dauphin Mariano Marcondes Ferraz Show more
Regulatory & Legal, News Article
13:20 03.12.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Central Bank Actions Market Sentiment Analysis Cryptocurrency & Blockchain Regulations Inflation Rates & CPI Data Decentralized Finance (DeFi) Innovations Banking Regulations Corporate Responsibility & ESG Cryptocurrency Regulations Mergers & Acquisitions Tokenomics and Crypto Economics SEC & Financial Compliance Anti-Money Laundering (AML) Regulations Hedge Funds & Private Equity Market Analysis and Predictions Banking & Investment Regulations Blockchain Technology Adoption Bond Market & Treasury Yields
Countries:
USA CHE CHN GBR IND JPN CAN ITA DEU RUS SGP KOR HKG FRA SLV AUS ARE IRL TUR SWE
Companies:
Coinbase Global, Inc. Solana USD Apple Inc. NVIDIA Corporation MicroStrategy Inc BlackRock, Inc. JPMorgan Chase & Co. Ripples USD Kraken Energy Corp. Bitwise Bitcoin ETF Ethereum USD Tesla, Inc. Chainlink USD Tether USDt CNY Novartis AG The Goldman Sachs Group, Inc. Bank of America Corporation UBS Group AG CRISPR Therapeutics AG Grayscale Litecoin Trust
Currencies:
United States Dollar Euro Swiss Franc British Pound Sterling Chinese Yuan Indian Rupee Japanese Yen Canadian Dollar Australian Dollar South Korean Won Russian Ruble Hong Kong Dollar Bahamian Dollar Malaysian Ringgit United Arab Emirates Dirham Swedish Krona Thai Baht Danish Krone Mongolian Tögrög
People:
Donald Trump Elon Musk Gary Gensler Ali Martinez Joe Biden Paul Atkins Michael J. Saylor Peter Brandt David O. Sacks Brad Garlinghouse Paul Grewal Stephanos Bibas Changpeng Zhao Scott Bessent Nate Geraci Charles Hoskinson Cynthia Lummis Zach Pandl Helen Hayes Paolo Ardoino

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings